Key references

2..  Neurofibromatosis. National Institutes of Health Consensus Development Conference Consensus Statement 1987;6:1–7.

4.. Listernick R, Ferner RE, Piersall L, et al: Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology  2004; 63:1944-1946.

6.. Habiby R, Silverman B, Listernick R, et al: Precocious puberty in children with neurofibromatosis type 1. J Pediatr  1995; 126:364-367.

7.. Listernick R, Ferner RE, Liu GT, et al: Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol  2007; 61:189-198.

9.. Sharif S, Ferner R, Birch JM, et al: Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol  2006; 24:2570-2575.

16.. Gutmann DH, Donahoe J, Brown T, et al: Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol  2000; 26:361-367.

43.. Bajenaru ML, Hernandez MR, Perry A, et al: Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res  2003; 63:8573-8577.

45.. Bajenaru ML, Garbow JR, Perry A, et al: Natural history of neurofibromatosis 1-associated optic nerve glioma in mice. Ann Neurol  2005; 57:119-127.

53.. Dasgupta B, Gutmann DH: Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci  2005; 25:5584-5594.

54.. Hegedus B, Dasgupta B, Shin JE, Emnett RJ, et al: Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell  2007; 1:443-457.